查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495536

非诺贝林市场：按产品类型、应用和最终用途划分 - 全球预测 2024-2030

Fenoverine Market by Product Type (Capsules, Tablets), Application (Abdominal Spasms, Stomach Spasms), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年苯诺维林市场规模为2.2654亿美元，2024年达2.3771亿美元，预计2030年将达3.1932亿美元，复合年增长率为5.02%。

非诺贝林是一种主要用于治疗各种消化系统疾病的药物。透过放鬆胃肠道的平滑肌，苯诺维林可以缓解腹痛、腹胀和不适等症状，这些症状通常与大肠激躁症和类似的消化系统疾病有关。非诺贝林被归类为解痉药，可减少消化器官系统痉挛和不自主的肌肉收缩。这一动作可以改善患有这些问题的患者的舒适度和消化功能。全球胃肠道疾病（包括大肠激躁症和痉挛性疼痛）盛行率不断上升，以及对开发更安全、更有效製剂的稳定投资正在推动市场成长。然而，替代治疗技术和药物的可用性以及苯诺维林的严重副作用可能会阻碍市场的采用。然而，改进的药物输送系统（如缓释性胶囊和水溶性锭剂）的开发，以及製药公司和学术机构之间合作的加强，预计将推动苯诺威林研发过程的创新和效率。市场创造进一步的成长机会。

主要市场统计
基准年[2023] 22654万美元
预测年份 [2024] 23771万美元
预测年份 [2030] 31932万美元
复合年增长率（%） 5.02%

区域洞察

美洲苯诺威林市场的成长主要是由于人们对大肠激躁症（IBS）和苯诺威林用于治疗的类似胃肠道疾病的认识不断提高。在这些地区，获得医疗保健服务的机会很高，患者通常对处方治疗表现出很高的依从性。最近的投资旨在改进配方并儘量减少可能的副作用。欧洲市场格局是动态的，受医疗保健政策和监管差异的影响，各国之间的市场动态有显着差异。近年来，欧洲在胃肠道疾病研究上投入大量资金，部分原因是欧盟卫生计画的资助。这可能会增加理解和认识，并增加对包括非诺贝林在内的治疗的需求。欧盟的专利活动主要围绕着改善现有药物的药理学特征和减少药物引起的副作用的发生率。由于最近努力改善医疗设施和跨国製药公司增加投资，中东和非洲的苯诺维林市场正在扩大。由于生活方式引起的胃肠道疾病的增加，特别是在都市区，亚太地区的苯维林市场呈现快速成长。一个主要驱动因素是整个亚太地区不断扩大的医疗基础设施以及政府为改善人口整体健康所做的努力。此外，先进的医学研究和製药创新已导致针对该主题申请了多项新专利_KEYWORD，重点关注增强的递送机制和联合治疗。

FPNV定位矩阵

FPNV 定位矩阵对于评估 Fenoberine 市场供应商定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对非诺贝林市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前非诺贝林市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对有效胃肠道治疗的认识与需求不断增强
      • 扩大医疗基础设施和政府努力
    • 抑制因素
      • 与苯诺维林相关的限制和副作用
    • 机会
      • 苯维林给药系统的进展
      • 联合研究和开发倡议
    • 任务
      • 假药的存在、替代治疗技术和药物的可用性
  • 市场区隔分析
    • 产品类型：极少的味道和气味使苯诺维林胶囊更受欢迎
    • 最终用途：家庭医疗保健环境中苯诺维林使用的演变
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章非诺贝林市场：依产品类型

  • 胶囊
  • 药片

第 7 章非诺贝林市场：依应用分类

  • 腹部绞痛
  • 胃痉挛

第 8 章 非诺贝林市场：依最终用途分类

  • 家庭健康环境
  • 医院/诊所

第九章 美洲非诺贝林市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太非诺贝林市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 非诺贝林欧洲、中东和非洲市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 布吉纳法索开设新製药厂以促进健康独立和经济成长
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-CB04E05652A0

[181 Pages Report] The Fenoverine Market size was estimated at USD 226.54 million in 2023 and expected to reach USD 237.71 million in 2024, at a CAGR 5.02% to reach USD 319.32 million by 2030.

Fenoverine is a pharmaceutical drug primarily used to treat various digestive disorders. It works by helping to relax the smooth muscles of the gastrointestinal tract, which can alleviate symptoms, including abdominal pain, bloating, and discomfort often associated with conditions including irritable bowel syndrome and similar gastrointestinal ailments. Fenoverine is classified as a spasmolytic agent, which helps reduce spasms or involuntary muscle contractions in the digestive system. This action helps improve the comfort and digestive function of patients experiencing these issues. The rising global incidence of gastrointestinal disorders, including irritable bowel syndrome and spasmodic pain, and the steady flow of investment into developing safer and more effective formulations drive the market growth. However, the availability of alternate therapeutic technologies and medicines coupled with significant side effects for fenoverine can deter the adoption of the market. Nevertheless, developing improved drug delivery systems, such as extended-release capsules or soluble tablets, and increasing collaborations between pharmaceutical companies and academic institutions are anticipated to spur innovation and efficiency in the R&D processes for fenoverine, further creating market growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 226.54 million
Estimated Year [2024] USD 237.71 million
Forecast Year [2030] USD 319.32 million
CAGR (%) 5.02%

Regional Insights

The market for fenoverine in the Americas shows growth, primarily due to the growing awareness of irritable bowel syndrome (IBS) and similar gastrointestinal conditions for which fenoverine is prescribed. In these regions, there is high access to healthcare services, and patients generally exhibit high compliance with prescribed treatments. Recent investments have been directed toward improving the formulation and minimizing possible side effects of the drug. The European market for fenoverine presents a varied landscape, with considerable differences in market dynamics from one country to another, influenced by differing healthcare policies and regulations. Recently, there has been significant investment in research into gastrointestinal diseases in Europe, partly funded by the EU's health programs. This has facilitated better understanding and awareness, potentially increasing the need for treatments, including fenoverine. Patent activity in the EU primarily revolves around improving the pharmacological profiles of existing drugs and reducing the incidence of drug-induced side effects. In the Middle East and Africa, the market for fenoverine is growing with recent initiatives aimed at boosting healthcare facilities, coupled with increasing investments from multinational pharmaceutical companies. The Asia-Pacific region is showcasing rapid growth in the fenoverine market, propelled by rising incidences of lifestyle-induced gastrointestinal disorders, particularly in urban areas. Expanding healthcare infrastructure and governmental initiatives to improve the population's general health across APAC are significant drivers. Furthermore, advanced medical research and pharmaceutical innovations have seen several new patents filed for fenoverine, focusing on enhanced delivery mechanisms and combination therapies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Fenoverine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing awareness and the need for effective gastrointestinal treatments
      • Expanding healthcare infrastructure and governmental initiatives
    • Market Restraints
      • Limitations and side effects associated with fenoverine
    • Market Opportunities
      • Advancements in drug delivery systems for fenoverine
      • Collaborative research and development initiatives
    • Market Challenges
      • Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines
  • Market Segmentation Analysis
    • Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
    • End-Use: Evolving usage of fenoverine in home healthcare settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fenoverine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fenoverine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth

Burkina Faso inaugurated its pharmaceutical manufacturing plant to produce low-cost generic drugs, primarily targeting the local supply of essential medications. Under the entity Propharm, Burkinabe pharmacists reported that the new facility initially focused on medications such as paracetamol, the antispasmodic agent phloroglucinol, and treatments for diarrhea, including oral rehydration salts and zinc. Situated on a 1.5-hectare site near Ouagadougou in Komsilga, this plant represents a critical step toward self-reliance, addressing the frequent shortages and high costs of drugs exacerbated by the heavy reliance on imports [Published On: 2023-05-29]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fenoverine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fenoverine Market, highlighting leading vendors and their innovative profiles. These include American Custom Chemicals Corporation, Dayang Chem (Hangzhou) Co.,Ltd., Enomark, JoinHub Pharma, LGC Limited, Mars Therapeutics Private Limited, Medical Isotopes, Inc., Micro Labs Limited, Sri Krishna Pharmaceuticals Ltd., Synmosa Biopharma Corporation, and Taj Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Fenoverine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Capsules
    • Tablets
  • Application
    • Abdominal Spasms
    • Stomach Spasms
  • End-Use
    • Home Healthcare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and the need for effective gastrointestinal treatments
      • 5.1.1.2. Expanding healthcare infrastructure and governmental initiatives
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations and side effects associated with fenoverine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in drug delivery systems for fenoverine
      • 5.1.3.2. Collaborative research and development initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
    • 5.2.2. End-Use: Evolving usage of fenoverine in home healthcare settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Fenoverine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Tablets

7. Fenoverine Market, by Application

  • 7.1. Introduction
  • 7.2. Abdominal Spasms
  • 7.3. Stomach Spasms

8. Fenoverine Market, by End-Use

  • 8.1. Introduction
  • 8.2. Home Healthcare Settings
  • 8.3. Hospitals & Clinics

9. Americas Fenoverine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fenoverine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fenoverine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FENOVERINE MARKET RESEARCH PROCESS
  • FIGURE 2. FENOVERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FENOVERINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FENOVERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FENOVERINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023